Fig. 3
From: Multi-omics characterization of early chronic obstructive pulmonary disease
Metabolic characterizations of biological ECOPD. (A) Pathway enrichment analysis of metabolites related to ECOPD. (B) Changes in tryptophan, adrenic acid, 2-hydroxyethanefulfonate and lysine in the validation cohort